74 related articles for article (PubMed ID: 24446942)
1. Trade-Related Aspects of Intellectual Property Rights Flexibilities and Public Health: Implementation of Compulsory Licensing Provisions into National Patent Legislation.
McGIVERN L
Milbank Q; 2023 Dec; 101(4):1280-1303. PubMed ID: 37646392
[TBL] [Abstract][Full Text] [Related]
2. Flexibilities provided by the Agreement on Trade-Related Aspects of Intellectual Property Rights.
Correa CM
Bull World Health Organ; 2018 Mar; 96(3):148. PubMed ID: 29531410
[No Abstract] [Full Text] [Related]
3. Management of intellectual property rights in India: An updated review.
Tiwari R; Tiwari G; Rai AK; Srivastawa B
J Nat Sci Biol Med; 2011 Jan; 2(1):2-12. PubMed ID: 22470229
[TBL] [Abstract][Full Text] [Related]
4. Research funders must join the fight for equal access to medicines.
Nature; 2024 Feb; 626(7997):7-8. PubMed ID: 38291143
[No Abstract] [Full Text] [Related]
5. Are drug companies living up to their human rights responsibilities? Moving toward assessment.
Gruskin S; Raad Z
PLoS Med; 2010 Sep; 7(9):e1000310. PubMed ID: 20927356
[TBL] [Abstract][Full Text] [Related]
6. The potential impact of the Comprehensive and Progressive Agreement for Prans-Pacific Partnership on Thailand's hepatitis C treatment program.
Tenni B; Lexchin J; Akaleephan C; Kittitrakul C; Gleeson D
Global Health; 2024 Jun; 20(1):46. PubMed ID: 38867208
[TBL] [Abstract][Full Text] [Related]
7. Decolonising human rights: how intellectual property laws result in unequal access to the COVID-19 vaccine.
Sekalala S; Forman L; Hodgson T; Mulumba M; Namyalo-Ganafa H; Meier BM
BMJ Glob Health; 2021 Jul; 6(7):. PubMed ID: 34253631
[TBL] [Abstract][Full Text] [Related]
8. Are We in a De-Globalization Process? The Evidence from Global Trade During 2007-2017.
Li X; Shen C; Cai H; Chen Q
Glob Chall; 2021 Aug; 5(8):2000096. PubMed ID: 34377531
[TBL] [Abstract][Full Text] [Related]
9. Radical Approaches During Unusual Circumstances: Intellectual Property Regulation and the COVID-19 Dilemma.
El Said M
Development (Rome); 2020; 63(2-4):209-218. PubMed ID: 33173258
[TBL] [Abstract][Full Text] [Related]
10. Intellectual property and assisted reproductive technology.
Cyranoski D; Contreras JL; Carrington VT
Nat Biotechnol; 2023 Jan; 41(1):14-20. PubMed ID: 36653491
[No Abstract] [Full Text] [Related]
11. Contracts and intellectual property rights in translational R&D: furthering safeguards in the public interest.
Anderson M; Hawkins N; Slade A
Nat Biotechnol; 2024 Feb; 42(2):179-182. PubMed ID: 38361056
[No Abstract] [Full Text] [Related]
12. Revisiting the Corporate and Commercial Determinants of Health.
McKee M; Stuckler D
Am J Public Health; 2018 Sep; 108(9):1167-1170. PubMed ID: 30024808
[TBL] [Abstract][Full Text] [Related]
13. Country and regional variations in purchase prices for essential cancer medications.
Cuomo RE; Seidman RL; Mackey TK
BMC Cancer; 2017 Aug; 17(1):566. PubMed ID: 28836947
[TBL] [Abstract][Full Text] [Related]
14. The ethics of intellectual property rights in an era of globalization.
Shah AK; Warsh J; Kesselheim AS
J Law Med Ethics; 2013; 41(4):841-51, Table of Contents. PubMed ID: 24446942
[TBL] [Abstract][Full Text] [Related]
15. Analyzing the impact of trade and investment agreements on pharmaceutical policy: provisions, pathways and potential impacts.
Gleeson D; Lexchin J; Labonté R; Townsend B; Gagnon MA; Kohler J; Forman L; Shadlen KC
Global Health; 2019 Nov; 15(Suppl 1):78. PubMed ID: 31775767
[TBL] [Abstract][Full Text] [Related]
16. Trade, TRIPS, and pharmaceuticals.
Smith RD; Correa C; Oh C
Lancet; 2009 Feb; 373(9664):684-91. PubMed ID: 19167054
[TBL] [Abstract][Full Text] [Related]
17. [Essential medicines and the TRIPS Agreement: collision between the right to health and intellectual property rights].
Allard Soto R
Salud Colect; 2015 Mar; 11(1):9-21. PubMed ID: 25853827
[TBL] [Abstract][Full Text] [Related]
18. What is the impact of intellectual property rules on access to medicines? A systematic review.
Tenni B; Moir HVJ; Townsend B; Kilic B; Farrell AM; Keegel T; Gleeson D
Global Health; 2022 Apr; 18(1):40. PubMed ID: 35428250
[TBL] [Abstract][Full Text] [Related]
19. [Evolution of the international intellectual property rights system: patent protection for the pharmaceutical industry and access to medicines].
Chaves GC; Oliveira MA; Hasenclever L; de Melo LM
Cad Saude Publica; 2007 Feb; 23(2):257-67. PubMed ID: 17221075
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
